- Exchange: NASDAQ GM
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharma
Omeros Corp+ Add to Watchlist
OMER:US12.8500 USD 0.5200 4.22%
As of 16:30:00 ET on 08/22/2014.
Company Profile for Omeros Corp (OMER)
Omeros Corporation is a biopharmaceutical company developing a pipeline of product candidates for use in orthopedics, rheumatology, urology, cardiovascular medicine, general surgery and pain management.
Key Executives for Omeros Corp (OMER)
|Gregory A DemopulosChairman/Pres/CEO/Co-Founder||Michael A JacobsenVP:Finance/Chief Acctg Officer|
|George A GaitanarisVP:Science/Chief Scientific Ofcr||J Steven WhitakerVP:Clinical/Chief Medical Ofcr|
|Kenneth M FergusonVP:Dev/Chief Dev Ofcr||Marcia S KelbonVP:Patent/Secy/General Counsel|
|Albert S YuVP:Clinical Development||Michael K InouyeVP:Commercial Operations|
|Catherine A Melfi "Cathy"VP:Regulatory Affairs||Timothy M DuffyVP:Business Development|